147 related articles for article (PubMed ID: 37742028)
1. Paxlovid-tacrolimus drug-drug interaction caused severe diarrhea that induced combined diabetic ketoacidosis and a hyperglycemic hyperosmolar state in a kidney transplant patient: a case report.
Luo W; He Y; Wei MG; Lu GB; Yi Q
J Med Case Rep; 2023 Sep; 17(1):406. PubMed ID: 37742028
[TBL] [Abstract][Full Text] [Related]
2. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.
Young C; Papiro T; Greenberg JH
Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345
[TBL] [Abstract][Full Text] [Related]
3. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report.
Prikis M; Cameron A
Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203
[TBL] [Abstract][Full Text] [Related]
4. Diabetic ketoacidosis associated with tacrolimus in solid organ transplant recipients.
Masood MQ; Rabbani M; Jafri W; Habib M; Saleem T
J Pak Med Assoc; 2011 Mar; 61(3):288-90. PubMed ID: 21465949
[TBL] [Abstract][Full Text] [Related]
5. Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient.
Modi S; Kahwash R; Kissling K
Eur Heart J Case Rep; 2023 May; 7(5):ytad193. PubMed ID: 37252201
[TBL] [Abstract][Full Text] [Related]
6. Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.
Xiong Y; Wang X; Li S; Zhang Q; Guo L; Chen W; Zhao Z; Liu L
Front Pharmacol; 2023; 14():1285078. PubMed ID: 38026995
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
Solmaz S; Gökgöz Z; Gereklioğlu Ç; Yeral M; Boğa C; Özdoğu H
Exp Clin Transplant; 2017 Dec; 15(6):702-703. PubMed ID: 26643544
[TBL] [Abstract][Full Text] [Related]
8. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.
Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G
BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus-induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient.
Mazumder MA; Gulati S; Narula AS; Shehwar D; Mir IM
Pediatr Transplant; 2022 Mar; 26(2):e14194. PubMed ID: 34854174
[TBL] [Abstract][Full Text] [Related]
10. A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant recipient.
Lo CM; Chen WH; Tsai MY; Lu HI; Hsiao YH; Chuang KH; Chen Y; Wu HF; Huang KT; Wang YH
J Cardiothorac Surg; 2024 Mar; 19(1):132. PubMed ID: 38491538
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.
Yoshida EM; Buczkowski AK; Sirrs SM; Elliott TG; Scudamore CH; Levin A; Tildesley HD; Landsberg DN
Transpl Int; 2000; 13(1):69-72. PubMed ID: 10743693
[TBL] [Abstract][Full Text] [Related]
12. Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease.
Zaarur L; Patel A; Pasternak B
JPGN Rep; 2023 Nov; 4(4):e352. PubMed ID: 38034448
[TBL] [Abstract][Full Text] [Related]
13. Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient.
Maynard RD; Bates P; Korpi-Steiner N
Pract Lab Med; 2023 Aug; 36():e00322. PubMed ID: 37649541
[TBL] [Abstract][Full Text] [Related]
14. Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient.
Shah A; Nasrullah A; Butt MA; Young M
Eur J Case Rep Intern Med; 2022; 9(9):003528. PubMed ID: 36299835
[TBL] [Abstract][Full Text] [Related]
15. Nirmatrelvir/ritonavir-induced elevation of blood tacrolimus levels in a patient in the maintenance phase post liver transplantation.
Shiohira H; Arakaki S; Uehara W; Uehara H; Yamamoto K; Nakamura K
J Infect Chemother; 2024 Jan; 30(1):77-80. PubMed ID: 37689137
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection.
Chen Y; Wan W; Yao X; Guan Y
J Neuroimmunol; 2023 Dec; 385():578245. PubMed ID: 37992586
[TBL] [Abstract][Full Text] [Related]
17. Paxlovid-Tacrolimus Drug-Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19.
Berar Yanay N; Bogner I; Saker K; Tannous E
Clin Drug Investig; 2022 Aug; 42(8):693-695. PubMed ID: 35816278
[No Abstract] [Full Text] [Related]
18. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.
Marsh J; Logan AT; Bilgili EP; Bowman LJ; Webb AR
Am J Health Syst Pharm; 2024 Jun; 81(13):e345-e352. PubMed ID: 38347740
[TBL] [Abstract][Full Text] [Related]
19. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States.
Abbott KC; Bernet VJ; Agodoa LY; Yuan CM
BMC Endocr Disord; 2003 Mar; 3(1):1. PubMed ID: 12659645
[TBL] [Abstract][Full Text] [Related]
20. Effect of Paxlovid on Tacrolimus Concentration in Perioperative Kidney Transplant Patients Infected With COVID-19: A Case Report.
Liu Y; Liu Y; Cai C; Hui F; Zhang Y; Wang B; Wang X; Zhang Y; Song X; He L; Yang H
Transplant Proc; 2023 Oct; 55(8):1822-1825. PubMed ID: 37558545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
